Novo, Novartis, BMS among pharmas celebrating LGBTQ+ Pride month on social media apark Wed, 06/12/2024 - 11:42

WuXi shares jump after BIOSECURE Act's exclusion from defense spending bill zbecker Wed, 06/12/2024 - 11:09

Junshi, Coherus' PD-1 inhibitor Loqtorzi scores in phase 3 liver cancer trial kdunleavy Wed, 06/12/2024 - 10:59

BMS chief Boerner says company is still open to deals after spending more than $20B on M&A last year fkansteiner Wed, 06/12/2024 - 10:41

Amid FTC crackdown, judge says Teva inhaler patents are 'improperly listed' in FDA Orange Book fkansteiner Wed, 06/12/2024 - 09:14

Analysts tip Lilly’s Alzheimer’s launch to boost rival Leqembi ntaylor Wed, 06/12/2024 - 08:57